Vimian Group AB (publ)
OTC: VIMGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Alireza Tajbakhsh
- Employees
- 1,200
- Headquarters
- Stockholm, Sweden
- IPO year
- 2022
- Market cap
- $1.5B
- Website
- https://vimian.com
Loading VIMGF…
Loading profile data…Frequently asked questions about VIMGF
What does Vimian Group AB (publ) (VIMGF) do?
Vimian Group AB (publ) is an international enterprise focused on the animal health sector, organized into four distinct divisions: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers a range of proprietary diagnostic tools and treatments under its Nextmune brand, providing both prescription and non-prescription op...
Where does VIMGF trade?
Vimian Group AB (publ) (VIMGF) trades on the Other OTC.
What sector is VIMGF in?
Vimian Group AB (publ) (VIMGF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Vimian Group AB (publ)?
Alireza Tajbakhsh is the chief executive officer of Vimian Group AB (publ) (VIMGF).
Where is Vimian Group AB (publ) headquartered?
Vimian Group AB (publ) is headquartered in Sweden.
Does VIMGF pay a dividend?
Vimian Group AB (publ) (VIMGF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIMGF go public?
Vimian Group AB (publ) (VIMGF) completed its initial public offering in 2022.